ALLO-501,allo-501A
allogene therapeutics
['lymphoma', 'allogene therap', '$allo']
$allo allogene therapeutics presents updated allo-501/501a phase 1 data in large b cell lymphoma at the american society of clinical oncology (asco) annual meeting. allogeneic car t product candidates have the potential to break down widespread acces... 
Financial news recaps and ticker rating curated by AI language models. Fine tuned on analyst articles and return alpha. More exposure to lesser known companies.